Cite
MLA Citation
Wenting Yan et al.. “Lobaplatin-based neoadjuvant chemotherapy for triple-negative breast cancer: a 5-year follow-up of a randomized, open-label, phase II trial.” Therapeutic advances in medical oncology, vol. 14, 2022, p. . http://access.bl.uk/ark:/81055/vdc_100169888349.0x0000f6